Christopher Blanchette

Dr. Blanchette is Vice President, Evidence Strategy, Generation & Communication for Precision Health Economics, part of Precision for Medicine. He has focused his career on assessing real-world clinical and economic outcomes associated with the use of pharmaceuticals, biologics and devices. He was formerly a Principal & the Americas Leader for the Retrospective Outcomes Research Center of Excellence at IMS Health. He also previously directed the Division of Clinical & Outcomes Research at the Lovelace Respiratory Research Institute, which included the clinical research, biostatistics and outcomes research programs for the institute including over 50 employees actively devoted to research in respiratory and related diseases in six sites across the US. Chris also served in payer marketing and health economics and outcomes research roles for GlaxoSmithKline, Otsuka America Pharmaceutical Inc., and the Premier Hospital Alliance. He completed a summer fellowship at the Agency for Healthcare Research and Quality (AHRQ). Dr. Blanchette is a peer reviewer for AHRQ’s Health Information Technology Research study section, the Patient-Centered Outcomes Research Institute (PCORI) and many clinical and economics journals. He is a member of the editorial board for the Journal of Medical Economics and Current Medical Research and Opinion. He is a member of the International Society for Pharmacoeconomics and Outcomes Research, the International Society of Pharmacoepidemiology, and the Academy for Managed Care Pharmacy.

Dr. Blanchette is also the Director of the Data Science Initiative for the College of Health & Human Services and a tenured Associate Professor of Public Health Sciences at the University of North Carolina at Charlotte. He also maintains adjunct faculty positions with the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, and the Erivan K. Haub School of Business at Saint Joseph’s University. He has post-graduate training in research management from Duke University, a Ph.D. in Pharmaceutical Health Services Research and M.S. in Epidemiology from the University of Maryland; a M.B.A. in Pharmaceutical & Healthcare Marketing from Saint Joseph’s University and a M.A. in Sociology, B.S. in Psychology and B.A. in History from the University of North Carolina at Charlotte.